Psychopharmacology and Psychiatry Updates
Un pódcast de Psychopharmacology Institute
Categorías:
213 Episodo
-
Medications for Binge Eating Disorder
Publicado: 17/4/2022 -
Antipsychotics for First Episodes of Psychosis
Publicado: 12/4/2022 -
Effects on Suicidal Risk With Different Medications
Publicado: 7/4/2022 -
Risks of Using Cannabinoids
Publicado: 2/4/2022 -
Lithium: How to Manage Dosage
Publicado: 28/3/2022 -
CBD as a Medication
Publicado: 23/3/2022 -
SSRIs and Suicidality
Publicado: 18/3/2022 -
Cannabis and Cognition
Publicado: 13/3/2022 -
Clozapine-Induced Myocarditis
Publicado: 8/3/2022 -
Does Cannabis Use Cause Psychiatric Disorders?
Publicado: 3/3/2022 -
Treatment Strategies for Treatment-Resistant OCD
Publicado: 26/2/2022 -
Lithium Augmentation for Psychotic Depression
Publicado: 21/2/2022 -
Prevention and Treatment Strategies for Agitation and Dementia
Publicado: 16/2/2022 -
Choosing an Antipsychotic for Psychotic Depression
Publicado: 11/2/2022 -
Neurological and Psychiatric Sequelae Due to COVID-19
Publicado: 6/2/2022 -
SNRIs + Antipsychotics for Psychotic Depression
Publicado: 1/2/2022 -
Approaches for Addressing Tobacco Use Disorder
Publicado: 27/1/2022 -
ECT the First-Choice Treatment for Psychotic Depression
Publicado: 22/1/2022 -
Metabolic Characteristics of Newer Second-Generation Antipsychotics
Publicado: 17/1/2022 -
Prescribing Antipsychotics During Breastfeeding
Publicado: 12/1/2022
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.